Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2016

May 6, 2016

34395_dirs_2016-05-06_e471681a-d278-4ede-8ded-d9750a77d7e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-04

Reporting Person: Innes Guy Archibald (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-04 Warrant (Right to Buy) $2.6 D 74821 Disposed 2016-05-10 Common Stock (74821) Direct
2016-05-04 Warrant (Right to Buy) $2.6 A 74821 Acquired 2017-05-10 Common Stock (74821) Direct
2016-05-04 Warrant (Right to Buy) $2.6 D 1786 Disposed 2016-05-10 Common Stock (1786) Indirect
2016-05-04 Warrant (Right to Buy) $2.6 A 1786 Acquired 2017-05-10 Common Stock (1786) Indirect

Footnotes

F1: The four reported transactions involved an amendment of two outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of two "replacement" warrants. The warrants were originally granted on May 11, 2012 with an expiration date of May 10, 2016. The expiration date of the warrants was extended one year to May 10, 2017.

F2: The foregoing warrant was placed in a bare trust, which is not a separate legal entity, of which Mr. Innes is the Trustee, for the benefit of certain minors.